We are live on ! Find out more
RVPH

REVIVA PHARMA HLDGS INC
RVPH

Delisted

RVPH was delisted on the 13th of May, 2026.

Back to rankings

48 hedge funds and large institutions have $3.18M invested in REVIVA PHARMA HLDGS INC in 2025 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

642% more call options, than puts

Call options by funds: $1.83M | Put options by funds: $246K

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

50% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 8

14% more funds holding

Funds holding: 42 → 48 (+6)

0.19% less ownership

Funds ownership: 0.69% → 0.49% (-0.19%)

10% less capital invested

Capital invested by funds: $3.52M → $3.18M (-$337K)

Holders
48
Holders Change
+6
Holders Change %
+14.29%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
12
Reduced
8
Closed
9
Calls
$1.83M
Puts
$246K
Net Calls
+$1.58M
Net Calls Change
+$1.03M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$709K
2
Jane Street
Jane Street
New York
+$371K
3
Citadel Advisors
Citadel Advisors
Florida
+$308K
4
Millennium Management
Millennium Management
New York
+$307K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$272K

Top Sellers

Rank Fund Capital Flow
1
DP
Diadema Partners
New Jersey
-$1.39M
2
PAP
Persistent Asset Partners
Hong Kong
-$330K
3
Renaissance Technologies
Renaissance Technologies
New York
-$79.8K
4
Simplex Trading
Simplex Trading
Illinois
-$63K
5
Cetera Investment Advisers
Cetera Investment Advisers
Illinois
-$20.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Cetera Investment Advisers
26
Cetera Investment Advisers
Illinois
$6.64K -$20.1K -1,810 -60%
KAS
27
Kestra Advisory Services
Texas
$5.58K +$11.1K +1,000 New
VPIM
28
Vanguard Personalized Indexing Management
California
$5.33K -$2.67K -240 -20%
Citigroup
29
Citigroup
New York
$5.13K +$10.2K +919 New
LFG
30
Larson Financial Group
Missouri
$4.64K -$10.2K -918 -52%
Raymond James Financial
31
Raymond James Financial
Florida
$3.91K -$556 -50 -7%
Two Sigma Investments
32
Two Sigma Investments
New York
$3.87K -$4.4K -396 -36%
FHA
33
Flagship Harbor Advisors
Massachusetts
$3.5K +$6.97K +627 New
TWC
34
TD Waterhouse Canada
Ontario, Canada
$3.46K – – –
NWM
35
NRI Wealth Management
California
$3.17K -$556 -50 -8%
SA
36
Sanctuary Advisors
Indiana
$2.79K – – –
Northwestern Mutual Wealth Management
37
Northwestern Mutual Wealth Management
Wisconsin
$2.59K – – –
PUI
38
Purpose Unlimited Inc
$2.24K +$4.5K +405 New
SS
39
SBI Securities
Japan
$1.4K – – –
Fidelity Investments
40
Fidelity Investments
Massachusetts
$1.32K +$2.65K +238 New
IA
41
IFP Advisors
Florida
$1.12K – – –
Wells Fargo
42
Wells Fargo
California
$837 -$2.22K -200 -57%
FFO
43
Fortitude Family Office
Arizona
$687 +$1.37K +123 New
AWM
44
Activest Wealth Management
Florida
$279 – – –
VWM
45
Vermillion Wealth Management
Minnesota
$279 +$556 +50 New
Bank of America
46
Bank of America
North Carolina
$256 +$211 +19 +70%
TCM
47
Tradewinds Capital Management
Washington
$70 – – –
DP
48
Diadema Partners
New Jersey
– -$1.39M -125,346 Closed
PAP
49
Persistent Asset Partners
Hong Kong
– -$330K -29,695 Closed
Renaissance Technologies
50
Renaissance Technologies
New York
– -$79.8K -10,830 Closed
1
2
3

RVPH Hedge Fund Activity: Q4 2025 in Review

48 of the 8,252 institutional investors tracked by Wall St. Rank reported a position in REVIVA PHARMA HLDGS INC (RVPH) for Q4 2025, worth a combined $3.18M — down 9.6% from $3.52M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new RVPH positions and 9 closed out — a net gain of 6 holders — while 12 added to existing stakes and 8 trimmed.

The largest buyer was Vanguard Group, adding an estimated $709K. The largest seller was Diadema Partners, exiting entirely with an estimated $1.39M sold.

  • 48 institutional investors held REVIVA PHARMA HLDGS INC (RVPH) as of Q4 2025, up from 42 in Q3 2025.
  • Funds reported $3.18M of REVIVA PHARMA HLDGS INC stock for Q4 2025, down 9.6% quarter-over-quarter.
  • 15 funds opened new REVIVA PHARMA HLDGS INC positions in Q4 2025 and 9 closed out, a net change of +6 holders.
  • The largest REVIVA PHARMA HLDGS INC buyer in Q4 2025 was Vanguard Group, an estimated $709K added.
  • The largest REVIVA PHARMA HLDGS INC seller in Q4 2025 was Diadema Partners, an estimated $1.39M sold.

Based on aggregated 13F filings for Q4 2025.